Efficacy and Safety Study of Eprotirome in HeFH Patients Who Are on Optimal Standard of Care

Clinical trial NCT01410383 · TERMINATED

Trial details

NCT number: NCT01410383
Sponsor: Karo Bio AB
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Heterozygous Familial Hypercholesterolaemia

Start date: 2011-10-01
Primary completion: 2013-10-01
Enrollment: 236

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.